These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 16458428)
1. Allelic effects of mouse Pas1 candidate genes in human lung cancer cell lines. Galbiati F; Pettinicchio A; Dragani TA; Manenti G Cancer Lett; 2006 Dec; 244(2):176-81. PubMed ID: 16458428 [TBL] [Abstract][Full Text] [Related]
2. Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Manenti G; Galbiati F; Giannì-Barrera R; Pettinicchio A; Acevedo A; Dragani TA Oncogene; 2004 May; 23(25):4495-504. PubMed ID: 15064703 [TBL] [Abstract][Full Text] [Related]
3. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Wang M; Lemon WJ; Liu G; Wang Y; Iraqi FA; Malkinson AM; You M Cancer Res; 2003 Jun; 63(12):3317-24. PubMed ID: 12810665 [TBL] [Abstract][Full Text] [Related]
4. Pas1c1 is a candidate for the mouse pulmonary adenoma susceptibility 1 locus. Wang M; Futamura M; Wang Y; You M Oncogene; 2005 Mar; 24(11):1958-63. PubMed ID: 15688036 [TBL] [Abstract][Full Text] [Related]
5. Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors. Manenti G; Trincucci G; Pettinicchio A; Amendola E; Scarfò M; Dragani TA Oncogene; 2008 Sep; 27(43):5753-8. PubMed ID: 18560355 [TBL] [Abstract][Full Text] [Related]
6. Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations. Karasaki H; Obata M; Ogawa K; Lee GH Oncogene; 1997 Oct; 15(15):1833-40. PubMed ID: 9362450 [TBL] [Abstract][Full Text] [Related]
7. Outbred CD-1 mice carry the susceptibility allele at the pulmonary adenoma susceptibility 1 (Pas1) locus. Manenti G; Galbiati F; Noci S; Dragani TA Carcinogenesis; 2003 Jun; 24(6):1143-8. PubMed ID: 12807761 [TBL] [Abstract][Full Text] [Related]
8. Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Liu P; Wang Y; Vikis H; Maciag A; Wang D; Lu Y; Liu Y; You M Nat Genet; 2006 Aug; 38(8):888-95. PubMed ID: 16862160 [TBL] [Abstract][Full Text] [Related]
9. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218 [TBL] [Abstract][Full Text] [Related]
10. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
11. Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse. Manenti G; Gariboldi M; Elango R; Fiorino A; De Gregorio L; Falvella FS; Hunter K; Housman D; Pierotti MA; Dragani TA Nat Genet; 1996 Apr; 12(4):455-7. PubMed ID: 8630506 [TBL] [Abstract][Full Text] [Related]
12. Identification of RASSF8 as a candidate lung tumor suppressor gene. Falvella FS; Manenti G; Spinola M; Pignatiello C; Conti B; Pastorino U; Dragani TA Oncogene; 2006 Jun; 25(28):3934-8. PubMed ID: 16462760 [TBL] [Abstract][Full Text] [Related]
13. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
14. Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus. Liu PY; Vikis H; James M; Lu Y; Wang DL; Liu HB; Wen WD; Wang Y; You M Cancer Res; 2009 Aug; 69(15):6290-8. PubMed ID: 19622765 [TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282 [TBL] [Abstract][Full Text] [Related]
16. Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis. Manenti G; Dragani TA Carcinogenesis; 2005 May; 26(5):875-82. PubMed ID: 15471897 [TBL] [Abstract][Full Text] [Related]
17. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs. Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H Carcinogenesis; 2007 Apr; 28(4):777-84. PubMed ID: 17088259 [TBL] [Abstract][Full Text] [Related]
18. Linkage disequilibrium and physical mapping of Pas1 in mice. Manenti G; Stafford A; De Gregorio L; Gariboldi M; Falvella FS; Avner P; Dragani TA Genome Res; 1999 Jul; 9(7):639-46. PubMed ID: 10413402 [TBL] [Abstract][Full Text] [Related]
19. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. Zhang X; Zhang J; Wang L; Wei H; Tian Z BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]